BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23271315)

  • 41. Network-specific effects of age and in-scanner subject motion: a resting-state fMRI study of 238 healthy adults.
    Mowinckel AM; Espeseth T; Westlye LT
    Neuroimage; 2012 Nov; 63(3):1364-73. PubMed ID: 22992492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
    Förster S; Buschert VC; Buchholz HG; Teipel SJ; Friese U; Zach C; la Fougere C; Rominger A; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 25(4):695-706. PubMed ID: 21498904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease.
    Sorg C; Riedl V; Mühlau M; Calhoun VD; Eichele T; Läer L; Drzezga A; Förstl H; Kurz A; Zimmer C; Wohlschläger AM
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18760-5. PubMed ID: 18003904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
    Förster S; Buschert VC; Teipel SJ; Friese U; Buchholz HG; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 26 Suppl 3():337-48. PubMed ID: 21971473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basal functional connectivity within the anterior temporal network is associated with performance on declarative memory tasks.
    Gour N; Ranjeva JP; Ceccaldi M; Confort-Gouny S; Barbeau E; Soulier E; Guye M; Didic M; Felician O
    Neuroimage; 2011 Sep; 58(2):687-97. PubMed ID: 21722740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Instrumented Trail-Making Task to Differentiate Persons with No Cognitive Impairment, Amnestic Mild Cognitive Impairment, and Alzheimer Disease: A Proof of Concept Study.
    Zhou H; Sabbagh M; Wyman R; Liebsack C; Kunik ME; Najafi B
    Gerontology; 2017; 63(2):189-200. PubMed ID: 27855415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do the Cambridge Neuropsychological Test Automated Battery episodic memory measures discriminate amnestic mild cognitive impairment?
    Juncos-Rabadán O; Pereiro AX; Facal D; Reboredo A; Lojo-Seoane C
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):602-9. PubMed ID: 24150876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease.
    Peltsch A; Hemraj A; Garcia A; Munoz DP
    Eur J Neurosci; 2014 Jun; 39(11):2000-13. PubMed ID: 24890471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perspective taking abilities in amnestic mild cognitive impairment and Alzheimer's disease.
    Marková H; Laczó J; Andel R; Hort J; Vlček K
    Behav Brain Res; 2015 Mar; 281():229-38. PubMed ID: 25541035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in cognitive ability and hippocampal volume between Alzheimer's disease, amnestic mild cognitive impairment, and healthy control groups, and their correlation.
    Choi MH; Kim HS; Gim SY; Kim WR; Mun KR; Tack GR; Lee B; Choi YC; Kim HJ; Hong SH; Lim DW; Chung SC
    Neurosci Lett; 2016 May; 620():115-20. PubMed ID: 27019036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease.
    Richiardi J; Monsch AU; Haas T; Barkhof F; Van de Ville D; Radü EW; Kressig RW; Haller S
    Neurobiol Aging; 2015 Jan; 36(1):33-41. PubMed ID: 25146454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterizing topological patterns in amnestic mild cognitive impairment by quantitative water diffusivity.
    Zhang B; Zhang X; Zhang F; Li M; Schwarz CG; Zhang J; Yin Z; Qian L; Zhao H; Wang K; Tian C; Yu H; Chen W; Lu F; Wu W; Yang QX; Xu Y; Zhu B
    J Alzheimers Dis; 2015; 43(2):687-97. PubMed ID: 25114082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional cingulum disruption, not gray matter atrophy, detects cognitive changes in amnestic mild cognitive impairment subtypes.
    Chang YL; Chen TF; Shih YC; Chiu MJ; Yan SH; Tseng WY
    J Alzheimers Dis; 2015; 44(1):125-38. PubMed ID: 25190630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of a GSK-3β polymorphism with brain resting-state function in amnestic-type mild cognitive impairment.
    Bai F; Shi Y; Yuan Y; Yue C; Zhuang L; Xu X; Liu X; Zhang Z
    J Alzheimers Dis; 2012; 32(2):387-96. PubMed ID: 22785398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's disease and amnestic mild cognitive impairment weaken connections within the default-mode network: a multi-modal imaging study.
    Zhu DC; Majumdar S; Korolev IO; Berger KL; Bozoki AC
    J Alzheimers Dis; 2013; 34(4):969-84. PubMed ID: 23313926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resting state executive control network adaptations in amnestic mild cognitive impairment.
    Wu L; Soder RB; Schoemaker D; Carbonnell F; Sziklas V; Rowley J; Mohades S; Fonov V; Bellec P; Dagher A; Shmuel A; Jia J; Gauthier S; Rosa-Neto P
    J Alzheimers Dis; 2014; 40(4):993-1004. PubMed ID: 24583406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Makino T; Umegaki H; Suzuki Y; Yanagawa M; Nonogaki Z; Nakashima H; Kuzuya M
    Geriatr Gerontol Int; 2014 Oct; 14(4):819-26. PubMed ID: 24215176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of a time-based prospective memory procedure in the assessment of amnestic mild cognitive impairment.
    Costa A; Fadda L; Perri R; Brisindi M; Lombardi MG; Caltagirone C; Carlesimo GA
    J Alzheimers Dis; 2015; 44(1):63-7. PubMed ID: 25208618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.